Yolande Saab
Impact in
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Drug-Induced Hepatotoxicity and Protection 2
- Pharmacy and Medical Practices 2
-
- Pharmaceutical Practices and Patient Outcomes 4
- Co-authors
- Habib El-Moalem (2 shared papers)Andrew Overall (1 shared paper)Mohamad Mroueh (1 shared paper)Raed Rizkallah (1 shared paper)Paul R. Gard (2 shared papers)Shereen Nabhani‐Gebara (1 shared paper)Mark S. Yeoman (1 shared paper)Bechara Mfarrej (1 shared paper)
- Journals
- Genetics Research (1 paper)Phytotherapy Research (1 paper)The Pharmacogenomics Journal (1 paper)Environmental Science and Pollution Research (1 paper)Therapeutics and Clinical Risk Management (1 paper)
- Partner nations
- LebanonUnited KingdomGreece
In The Last Decade
Yolande Saab
14 papers receiving 334 citations
Peers
Comparison fields: 5 of 101
- Geriatrics and Gerontology 51
- Family Practice 14
- Pharmacology 52
- Biological Psychiatry 10
- Applied Microbiology and Biotechnology 8
Countries citing papers authored by Yolande Saab
This map shows the geographic impact of Yolande Saab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolande Saab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolande Saab more than expected).
Fields of papers citing papers by Yolande Saab
This network shows the impact of papers produced by Yolande Saab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolande Saab. The network helps show where Yolande Saab may publish in the future.
Co-authors
The 19 scholars most cited alongside Yolande Saab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 67 | |
| 2 | 2019 | 54 | |
| 3 | 2007 | 53 | |
| 4 | 2004 | 51 | |
| 5 | 2006 | 38 | |
| 6 | 2007 | 16 | |
| 7 | 2022 | 16 | |
| 8 | 2010 | 16 | |
| 9 | 2015 | 11 | |
| 10 | 2019 | 10 | |
| 11 | 2021 | 4 | |
| 12 | 2011 | 4 | |
| 13 | 2023 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2004 | 1 | |
| 16 | 2024 | 0 |
About Yolande Saab
Yolande Saab is a scholar working on Pharmacology, Geriatrics and Gerontology, Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 16 papers that have together received 344 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (2 papers), Renin-Angiotensin System Studies (2 papers), Hormonal Regulation and Hypertension (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Pharmacy and Medical Practices (2 papers). The work is most often cited by research in Geriatrics and Gerontology (51 citations), Family Practice (14 citations), Pharmacology (52 citations), Biological Psychiatry (10 citations) and Applied Microbiology and Biotechnology (8 citations). Yolande Saab has collaborated with scholars based in Lebanon, United Kingdom and Greece. Frequent co-authors include Habib El-Moalem, Andrew Overall, Mohamad Mroueh, Raed Rizkallah, Paul R. Gard, Shereen Nabhani‐Gebara, Mark S. Yeoman, Bechara Mfarrej, James Barker and Stephen Barton. Their work appears in journals such as Genetics Research, Phytotherapy Research, The Pharmacogenomics Journal, Environmental Science and Pollution Research and Therapeutics and Clinical Risk Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.